Go offline with the Player FM app!
Cholesterol Breakthroughs From the AHA Meeting in New Orleans
Manage episode 518755080 series 3310873
Dr. Koren joins Kevin Geddings to report live from the American Heart Association meeting in New Orleans with fresh results on LDL lowering, prevention, and the future of gene editing for cholesterol. They discuss the excitement of big meetings like the AHA and how results can even surprise the investigators that were working on a study.
Note: Dr. Koren refers to CRISPR Therapeutics, a company developing gene-based cholesterol lowering technologies. CRISPR-Cas9 is also the general name of a gene editing technique.
Be a part of advancing science by participating in clinical research.
Have a question for Dr. Koren? Email him at [email protected]
Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube
Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn
Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com
Music: Storyblocks - Corporate Inspired
Thank you for listening!
Chapters
1. Live From AHA: Why Conferences Matter (00:00:00)
2. Big Wins In Cholesterol Research (00:01:17)
3. Vesalia Trial: Repatha Prevents Events (00:02:14)
4. How Patients Help Advance Medicine (00:03:18)
5. Gene Editing For Lifelong LDL Control (00:03:52)
6. Inside The Reveal: How Findings Emerge (00:05:03)
7. New Insights: Thick Heart, New Surgery (00:05:37)
8. MedEvidence: Truth Behind The Data (00:06:13)
9. Where To Learn More (00:07:07)
368 episodes
Manage episode 518755080 series 3310873
Dr. Koren joins Kevin Geddings to report live from the American Heart Association meeting in New Orleans with fresh results on LDL lowering, prevention, and the future of gene editing for cholesterol. They discuss the excitement of big meetings like the AHA and how results can even surprise the investigators that were working on a study.
Note: Dr. Koren refers to CRISPR Therapeutics, a company developing gene-based cholesterol lowering technologies. CRISPR-Cas9 is also the general name of a gene editing technique.
Be a part of advancing science by participating in clinical research.
Have a question for Dr. Koren? Email him at [email protected]
Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube
Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn
Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com
Music: Storyblocks - Corporate Inspired
Thank you for listening!
Chapters
1. Live From AHA: Why Conferences Matter (00:00:00)
2. Big Wins In Cholesterol Research (00:01:17)
3. Vesalia Trial: Repatha Prevents Events (00:02:14)
4. How Patients Help Advance Medicine (00:03:18)
5. Gene Editing For Lifelong LDL Control (00:03:52)
6. Inside The Reveal: How Findings Emerge (00:05:03)
7. New Insights: Thick Heart, New Surgery (00:05:37)
8. MedEvidence: Truth Behind The Data (00:06:13)
9. Where To Learn More (00:07:07)
368 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.